Contact

All Stories

  1. Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline

    Article • ACR Open Rheumatology, November 2020, Wiley

    Dr. Jasvinder A. Singh

  2. The death rate between Lupus and non-lupus Hospitalizations is declining

    Article • Annals of the Rheumatic Diseases, November 2020, BMJ

    Dr. Jasvinder A. Singh

  3. Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time‐trends, Healthcare Utilization and In‐Hospital Mortality

    Article • Arthritis & Rheumatology, November 2020, Wiley

    Dr. Jasvinder A. Singh

  4. Reasons for hospitalizations for non-gout reasons and mortality in people with gout are changing

    Article • Rheumatology, November 2020, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  5. Management of Rheumatic Diseases During the COVID‐19 pandemic: A National Veterans Affairs Survey of Rheumatologists

    Article • Arthritis Care & Research, October 2020, Wiley

    Dr. Jasvinder A. Singh

  6. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice

    Article • Clinical Rheumatology, September 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  7. Which factors predict discordance between a patient and physician on a gout flare?

    Article • Rheumatology, August 2020, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  8. Sjogren’s syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study

    Article • BMC Musculoskeletal Disorders, July 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  9. Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study

    Article • July 2020, Research Square

    Dr. Jasvinder A. Singh

  10. Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacement

    Article • Scandinavian Journal of Rheumatology, July 2020, Taylor & Francis

    Dr. Jasvinder A. Singh

  11. Response to: ‘Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland’ by Quills et al

    Article • Annals of the Rheumatic Diseases, July 2020, BMJ

    Dr. Jasvinder A. Singh

  12. Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis

    Article • Joint Bone Spine, July 2020, Elsevier

    Dr. Jasvinder A. Singh

  13. Serious infections in people with systemic sclerosis: a national US study

    Article • June 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  14. Allopurinol versus febuxostat hypersensitivity reactions in the US elderly: differences in study outcomes and populations. Response to: ‘Correspondence to “Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims da...

    Article • Annals of the Rheumatic Diseases, June 2020, BMJ

    Dr. Jasvinder A. Singh

  15. Hypersensitivity reactions with allopurinol versus febuxostat in the US elderly. Response to: ‘Confunding by indication and ethnicity difference? Comment on ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims ...

    Article • Annals of the Rheumatic Diseases, June 2020, BMJ

    Dr. Jasvinder A. Singh

  16. Identifying Physician-perceived Barriers to Apragmatictreatment Trial Inrheumatoid Arthritis

    Article • June 2020, Research Square

    Dr. Jasvinder A. Singh

  17. Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: a study protocol for an OMERACT initiative

    Article • BMJ Open, June 2020, BMJ

    Dr. Jasvinder A. Singh

  18. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study

    Article • Clinical Rheumatology, May 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  19. Serious Infections in People with Systemic sclerosis: A National U.S. Study

    Article • April 2020, Research Square

    Dr. Jasvinder A. Singh

  20. Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty

    Article • Clinical Rheumatology, March 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  21. Sjogren’s Syndrome is associated with higher healthcare utilization after primary hip, but not primary knee arthroplasty: A U.S. cohort study

    Article • February 2020, Research Square

    Dr. Jasvinder A. Singh

  22. Acute kidney injury after primary total hip arthroplasty: a risk multiplier for complication, mortality, and healthcare utilization

    Article • February 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  23. National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality

    Article • PLoS ONE, February 2020, PLOS

    Dr. Jasvinder A. Singh

  24. Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data

    Article • Annals of the Rheumatic Diseases, February 2020, BMJ

    Dr. Jasvinder A. Singh

  25. Serious Infections in People with Scleroderma: A National U.S. Study

    Article • January 2020, Research Square

    Dr. Jasvinder A. Singh

  26. Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomes

    Article • Clinical Rheumatology, January 2020, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  27. Acute kidney injury is associated with increased healthcare utilization, complications, and mortality after primary total knee arthroplasty

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2020, SAGE Publications

    Dr. Jasvinder A. Singh

  28. Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2020, SAGE Publications

    Dr. Jasvinder A. Singh

  29. Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2020, SAGE Publications

    Dr. Jasvinder A. Singh

  30. Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty

    Article • Clinical Rheumatology, November 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  31. A Personalized Decision Aid to Help Women with Lupus Nephritis from Racially and Ethnically Diverse Backgrounds Make Decisions about Taking Immune-Blocking Medicines

    Article • October 2019, Patient-Centered Outcomes Reserach Institute

    Dr. Jasvinder A. Singh

  32. How Systemic Sclerosis Affects Healthcare Use and Complication Rates after Total Hip Arthroplasty

    Article • The Journal of Rheumatology, October 2019, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  33. Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study

    Article • Clinical Rheumatology, August 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  34. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort

    Article • The Journal of Rheumatology, August 2019, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  35. Are the days of missed or delayed diagnosis of gout over?

    Article • Nature Reviews Rheumatology, August 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  36. Correction to: Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS)

    Article • Clinical Rheumatology, July 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  37. Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study

    Article • Clinical Rheumatology, June 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  38. Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty

    Article • The Journal of Rheumatology, June 2019, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  39. Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample

    Article • Rheumatology, May 2019, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  40. Lupus is associated with poorer outcomes after primary total hip arthroplasty

    Article • Lupus, May 2019, SAGE Publications

    Dr. Jasvinder A. Singh

  41. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial

    Article • PLoS Medicine, May 2019, PLOS

    Dr. Jasvinder A. Singh

  42. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?

    Article • Drugs & Aging, April 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  43. Gout and chronic pain in older adults: a Medicare claims study

    Article • Clinical Rheumatology, March 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  44. Allopurinol compared to febuxostat for the risk of atrial fibrillation

    Article • European Heart Journal, March 2019, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  45. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population

    Article • BMC Nephrology, March 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  46. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy

    Article • Drugs, March 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  47. The association of gout with incident giant cell arteritis in older adults

    Article • Joint Bone Spine, March 2019, Elsevier

    Dr. Jasvinder A. Singh

  48. Gout and sexual function: patient perspective of how gout affects personal relationships and intimacy

    Article • BMC Rheumatology, February 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  49. Gout is associated with increased healthcare utilization after knee arthroplasty

    Article • Annals of the Rheumatic Diseases, February 2019, BMJ

    Dr. Jasvinder A. Singh

  50. Self-reported sleep quality and sleep disorders in people with physician-diagnosed gout: an Internet cross-sectional survey

    Article • January 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  51. Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS)

    Article • Clinical Rheumatology, January 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  52. The Third Biennial 2018 OMERACT First-time Participant Program: A Qualitative and Quantitative Study

    Article • The Journal of Rheumatology, January 2019, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  53. A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials

    Article • Arthritis Care & Research, January 2019, Wiley

    Dr. Jasvinder A. Singh

  54. Gout and the risk of Parkinson’s disease in older adults: a study of U.S. Medicare data

    Article • BMC Neurology, January 2019, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  55. Is there a role for cherries in the management of gout?

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2019, SAGE Publications

    Dr. Jasvinder A. Singh

  56. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

    Article • Arthritis Care & Research, November 2018, Wiley

    Dr. Jasvinder A. Singh

  57. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

    Article • Arthritis & Rheumatology, November 2018, Wiley

    Dr. Jasvinder A. Singh

  58. Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis

    Article • Therapeutic Advances in Musculoskeletal Disease, November 2018, SAGE Publications

    Dr. Jasvinder A. Singh

  59. Gout and dementia in the elderly: a cohort study of Medicare claims

    Article • BMC Geriatrics, November 2018, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  60. Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?

    Article • Arthritis Care & Research, October 2018, Wiley

    Dr. Jasvinder A. Singh

  61. Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?

    Article • Annals of the Rheumatic Diseases, October 2018, BMJ

    Dr. Jasvinder A. Singh

  62. Goals of gout treatment: a patient perspective

    Article • Clinical Rheumatology, August 2018, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  63. Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis

    Article • August 2018, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  64. Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data

    Article • BMJ Open, August 2018, BMJ

    Dr. Jasvinder A. Singh

  65. Gout and the risk of age-related macular degeneration in the elderly

    Article • PLoS ONE, July 2018, PLOS

    Dr. Jasvinder A. Singh

  66. Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data

    Article • RMD Open, July 2018, BMJ

    Dr. Jasvinder A. Singh

  67. Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients

    Article • June 2018, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  68. Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout

    Article • Arthritis Care & Research, April 2018, Wiley

    Dr. Jasvinder A. Singh

  69. Medication adherence among patients with gout: A systematic review and meta-analysis

    Article • Seminars in Arthritis and Rheumatism, April 2018, Elsevier

    Dr. Jasvinder A. Singh

  70. Any sleep is a dream far away: a nominal group study assessing how gout affects sleep

    Article • Rheumatology, February 2018, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  71. Septic Arthritis in Emergency Departments in the US : A National Study of Health Care Utilization and Time Trends

    Article • Arthritis Care & Research, January 2018, Wiley

    Dr. Jasvinder A. Singh

  72. The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study

    Article • Rheumatology Advances in Practice, January 2018, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  73. Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence

    Article • Journal of General Internal Medicine, December 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  74. Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials

    Article • December 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  75. Validation of a definition for flare in patients with established gout

    Article • Arthritis & Rheumatology, November 2017, Wiley

    Dr. Jasvinder A. Singh

  76. Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy

    Article • Cochrane Database of Systematic Reviews, November 2017, Wiley

    Dr. Jasvinder A. Singh

  77. Response to: ‘Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults’ by Lee and Song

    Article • Annals of the Rheumatic Diseases, November 2017, BMJ

    Dr. Jasvinder A. Singh

  78. Weight loss for overweight patients with knee or hip osteoarthritis

    Article • Cochrane Database of Systematic Reviews, November 2017, Wiley

    Dr. Jasvinder A. Singh, Dr. Hans Lund

  79. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

    Article • RMD Open, November 2017, BMJ

    Dr. Jasvinder A. Singh

  80. Patient-Reported Outcomes Can Be Used to Streamline Post-Total Hip Arthroplasty Follow-Up to High-Risk Patients

    Article • The Journal of Arthroplasty, November 2017, Elsevier

    Dr. Jasvinder A. Singh

  81. Correction to: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment

    Article • Health and Quality of Life Outcomes, October 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  82. Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study

    Article • October 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  83. Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an upper-middle income country on the GRADE approach

    Article • Health Policy and Planning, October 2017, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  84. GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale

    Article • Journal of Clinical Epidemiology, October 2017, Elsevier

    Dr. Jasvinder A. Singh

  85. GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist

    Article • Journal of Clinical Epidemiology, October 2017, Elsevier

    Dr. Jasvinder A. Singh

  86. GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence

    Article • Journal of Clinical Epidemiology, October 2017, Elsevier

    Dr. Jasvinder A. Singh

  87. GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process

    Article • Journal of Clinical Epidemiology, October 2017, Elsevier

    Dr. Jasvinder A. Singh

  88. Patient Burden of Axial Spondyloarthritis

    Article • JCR Journal of Clinical Rheumatology, October 2017, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  89. Response to: ’A response to Singh. “Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?”' by Valiyil and Schechter

    Article • Annals of the Rheumatic Diseases, September 2017, BMJ

    Dr. Jasvinder A. Singh

  90. Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults

    Article • Annals of the Rheumatic Diseases, September 2017, BMJ

    Dr. Jasvinder A. Singh

  91. Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives

    Article • Arthritis Care & Research, September 2017, Wiley

    Dr. Jasvinder A. Singh

  92. Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking

    Article • Annals of the Rheumatic Diseases, September 2017, BMJ

    Dr. Jasvinder A. Singh

  93. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment

    Article • Health and Quality of Life Outcomes, September 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  94. Gout and comorbidity: a nominal group study of people with gout

    Article • September 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  95. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies

    Article • Annals of the Rheumatic Diseases, September 2017, BMJ

    Dr. Jasvinder A. Singh

  96. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Article • The Lancet, September 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Kathryn H. Jacobsen, Dr Samer Hamidi, Mr Morteza Shamsizadeh, Professor Stefan Lorkowski, Professor David M. Pereira, Dr. Mohammad Hossein Khosravi, Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  97. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Article • The Lancet, September 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Kathryn H. Jacobsen, Dr Samer Hamidi, Mr Morteza Shamsizadeh, Professor Stefan Lorkowski, Professor David M. Pereira, Dr Amador Goodridge, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Prof.Dr. Adnan Kisa, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi, Dr/ Adj Prof Vijay Kumar Chattu

  98. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Article • The Lancet, September 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Kathryn H. Jacobsen, Dr Samer Hamidi, Professor Stefan Lorkowski, Professor David M. Pereira, Dr Amador Goodridge, Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Prof.Dr. Adnan Kisa, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  99. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Article • The Lancet, September 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Kathryn H. Jacobsen, Dr Samer Hamidi, Professor Stefan Lorkowski, Professor David M. Pereira, Dr Amador Goodridge, Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Professor Yousef Khader, Dr. Jasvinder A. Singh, Prof.Dr. Adnan Kisa, Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  100. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Article • The Lancet, September 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Kathryn H. Jacobsen, Dr Samer Hamidi, Mr Morteza Shamsizadeh, Professor Stefan Lorkowski, Professor David M. Pereira, Dr. Mohammad Hossein Khosravi, Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  101. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

    Article • The Journal of Arthroplasty, September 2017, Elsevier

    Dr. Jasvinder A. Singh

  102. The burden of septic arthritis on the U.S. inpatient care: A national study

    Article • PLoS ONE, August 2017, PLOS

    Dr. Jasvinder A. Singh

  103. Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis

    Article • Cochrane Database of Systematic Reviews, August 2017, Wiley

    Dr. Jasvinder A. Singh

  104. Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans

    Article • Arthritis Care & Research, August 2017, Wiley

    Dr. Jasvinder A. Singh

  105. Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Yuan-Pang Wang, Dr Samer Hamidi, Mr Morteza Shamsizadeh, Maysaa El Sayed Zaki, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Rajaa Al-Raddadi

  106. The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: findings from the global burden of disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Yuan-Pang Wang, Dr Samer Hamidi, Mr Morteza Shamsizadeh, Maysaa El Sayed Zaki, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Rajaa Al-Raddadi

  107. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Samer Hamidi, Professor David M. Pereira, Mr Raimundas Lunevicius, Dr. Jasvinder A. Singh, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  108. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Samer Hamidi, Maysaa El Sayed Zaki, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Rajaa Al-Raddadi, Professor Erkin Mirrakhimov

  109. Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Samer Hamidi, Mr Morteza Shamsizadeh, Maysaa El Sayed Zaki, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Rajaa Al-Raddadi

  110. Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Samer Hamidi, Denny John, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh

  111. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study

    Article • Sozial- und Präventivmedizin, August 2017, Springer Science + Business Media

    Dr Samer Hamidi, Mr Morteza Shamsizadeh, Professor David M. Pereira, Maysaa El Sayed Zaki, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Rajaa Al-Raddadi

  112. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets

    Article • The Journal of Rheumatology, August 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  113. Validating Rheumatoid Arthritis Remission Using the Patients’ Perspective: Results from a Special Interest Group at OMERACT 2016

    Article • The Journal of Rheumatology, August 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  114. Health Effects of Overweight and Obesity in 195 Countries over 25 Years

    Article • New England Journal of Medicine, July 2017, New England Journal of Medicine (NEJM/MMS)

    Mr Morteza Shamsizadeh, Professor Erkin Mirrakhimov, Tommi Vasankari, Dr Azmeraw Amare, Professor Yousef Khader, Dr. Jasvinder A. Singh, Rajaa Al-Raddadi

  115. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

    Article • The Lancet, July 2017, Elsevier

    Dr Yuan-Pang Wang, Dr Shariful Islam, Dr Samer Hamidi, Professor David M. Pereira, Dr Amador Goodridge, Denny John, Maysaa El Sayed Zaki, Professor Erkin Mirrakhimov, Dina Nur Anggraini Ningrum, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Wayne Gao, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Melkamu Merid Mengesha , Andrew T. Olagunju, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  116. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

    Article • Arthritis Care & Research, June 2017, Wiley

    Susan Goodman, Dr. Jasvinder A. Singh

  117. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

    Article • Arthritis & Rheumatology, June 2017, Wiley

    Susan Goodman, Dr. Jasvinder A. Singh

  118. Clinical Practice Guidelines: Incorporating Input From a Patient Panel

    Article • Arthritis Care & Research, June 2017, Wiley

    Susan Goodman, Dr. Jasvinder A. Singh

  119. Management of Gout

    Article • Annals of Internal Medicine, June 2017, American College of Physicians

    Dr. Jasvinder A. Singh

  120. Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data

    Article • Annals of the Rheumatic Diseases, June 2017, BMJ

    Dr. Jasvinder A. Singh

  121. Child and Adolescent Health From 1990 to 2015

    Article • JAMA Pediatrics, June 2017, American Medical Association (AMA)

    Kathryn H. Jacobsen, Professor David M. Pereira, Maysaa El Sayed Zaki, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Azmeraw Amare, Dr. Jasvinder A. Singh, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  122. Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials

    Article • Seminars in Arthritis and Rheumatism, June 2017, Elsevier

    Dr. Jasvinder A. Singh

  123. Receipt of Pain Management Information Preoperatively Is Associated With Improved Functional Gain After Elective Total Joint Arthroplasty

    Article • The Journal of Arthroplasty, June 2017, Elsevier

    Dr. Jasvinder A. Singh

  124. Health care utilization in patients with gout: a prospective multicenter cohort study

    Article • BMC Musculoskeletal Disorders, May 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  125. Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature

    Article • Systematic Reviews, May 2017, Springer Science + Business Media

    Mr Peter DH Wall, Dr. Jasvinder A. Singh

  126. Outcome Measures Used in Arthroplasty Trials: Systematic Review of the 2008 and 2013 Literature

    Article • The Journal of Rheumatology, May 2017, The Journal of Rheumatology

    Mr Peter DH Wall, Dr. Jasvinder A. Singh

  127. The OMERACT First-time Participant Program: Fresh Eye from the New Guys

    Article • The Journal of Rheumatology, May 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  128. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Article • Cochrane Database of Systematic Reviews, May 2017, Wiley

    Dr. Jasvinder A. Singh

  129. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

    Article • The Lancet, May 2017, Elsevier

    Maysaa El Sayed Zaki, Dr Wayne Gao, Dr Azmeraw Amare, Professor Yousef Khader, Dr. Jasvinder A. Singh, Professor Alina Rodriguez, Rajaa Al-Raddadi

  130. Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease

    Article • Mayo Clinic Proceedings, April 2017, Elsevier

    Dr. Jasvinder A. Singh

  131. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data

    Article • BMC Medicine, March 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  132. Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set

    Article • BMC Musculoskeletal Disorders, March 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  133. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes

    Article • BMC Cardiovascular Disorders, March 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  134. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis

    Article • Cochrane Database of Systematic Reviews, March 2017, Wiley

    Dr. Jasvinder A. Singh

  135. Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection

    Article • The Journal of Rheumatology, March 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  136. Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013: findings from the Global Burden of Disease Study 2013

    Article • Annals of the Rheumatic Diseases, February 2017, BMJ

    Dr Samer Hamidi, Maysaa El Sayed Zaki, Mr Raimundas Lunevicius, Dr. Jasvinder A. Singh

  137. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group

    Article • The Journal of Rheumatology, February 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  138. Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial

    Article • Clinical Rheumatology, February 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  139. Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial

    Article • BMC Musculoskeletal Disorders, January 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  140. Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group

    Article • BMC Musculoskeletal Disorders, January 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  141. Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis

    Article • The Journal of Rheumatology, January 2017, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  142. Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot study

    Article • BMC Musculoskeletal Disorders, January 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  143. An underlying diagnosis of osteonecrosis of bone is associated with worse outcomes than osteoarthritis after total hip arthroplasty

    Article • BMC Musculoskeletal Disorders, January 2017, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  144. Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?

    Article • Annals of the Rheumatic Diseases, December 2016, BMJ

    Dr. Jasvinder A. Singh

  145. Chasing crystals out of the body: will treat to serum urate target for gout help us get there?

    Article • Annals of the Rheumatic Diseases, December 2016, BMJ

    Dr. Jasvinder A. Singh

  146. The Association of Vibratory Perception and Muscle Strength With the Incidence and Worsening of Knee Instability: The Multicenter Osteoarthritis Study

    Article • Arthritis & Rheumatology, December 2016, Wiley

    Dr. Jasvinder A. Singh

  147. Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context

    Article • Arthritis Care & Research, November 2016, Wiley

    Dr. Jasvinder A. Singh

  148. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Article • Cochrane Database of Systematic Reviews, November 2016, Wiley

    Dr. Jasvinder A. Singh

  149. Gout: will the “King of Diseases” be the first rheumatic disease to be cured?

    Article • BMC Medicine, November 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  150. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures

    Article • Arthritis Care & Research, October 2016, Wiley

    Dr. Jasvinder A. Singh

  151. Racial differences in health-related quality of life and functional ability in patients with gout

    Article • Rheumatology, October 2016, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  152. Increasing comorbidity is associated with worsening physical function and pain after primary total knee arthroplasty

    Article • BMC Musculoskeletal Disorders, October 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  153. Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)

    Article • The Patient Patient-Centered Outcomes Research, October 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  154. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Article • The Lancet, October 2016, Elsevier

    Professor David M. Pereira, Dr marek majdan, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  155. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Article • The Lancet, October 2016, Elsevier

    Professor David M. Pereira, Dr marek majdan, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Yuan-Pang Wang, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Andrew T. Olagunju, Professor Alina Rodriguez, Dr. Bolajoko O. Olusanya, Dr/ Adj Prof Vijay Kumar Chattu

  156. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Article • The Lancet, October 2016, Elsevier

    Professor David M. Pereira, Dr marek majdan, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  157. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Article • The Lancet, October 2016, Elsevier

    Professor David M. Pereira, Dr marek majdan, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  158. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Article • The Lancet, October 2016, Elsevier

    Professor David M. Pereira, Dr marek majdan, Professor Erkin Mirrakhimov, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, Professor Amanda G Thrift, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya

  159. Does T'ai Chi Gait Reduce External Knee Adduction Moment?

    Article • The Journal of Alternative and Complementary Medicine, October 2016, Mary Ann Liebert Inc

    Dr. Jasvinder A. Singh

  160. Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims

    Article • September 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  161. Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis

    Article • Systematic Reviews, September 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  162. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis

    Article • BMC Medicine, September 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  163. Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies

    Article • Current Rheumatology Reports, September 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  164. Allopurinol and the risk of stroke in older adults receiving medicare

    Article • BMC Neurology, September 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  165. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

    Article • The Lancet, September 2016, Elsevier

    Dr Zahid A Butt, Professor David M. Pereira, Dr marek majdan, Dr Amador Goodridge, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  166. Correction to Lancet HIV 2016; 3: e361–87

    Article • The Lancet HIV, September 2016, Elsevier

    Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Professor David M. Pereira, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Dr. Bolajoko O. Olusanya

  167. Assessment of physical function and participation in chronic pain clinical trials

    Article • Pain, September 2016, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  168. Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis

    Article • The Journal of Rheumatology, September 2016, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  169. Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis

    Article • BMJ Open, September 2016, BMJ

    Dr. Jasvinder A. Singh

  170. Renal dosing of allopurinol results in suboptimal gout care

    Article • Annals of the Rheumatic Diseases, August 2016, BMJ

    Dr. Jasvinder A. Singh

  171. Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination

    Article • Arthritis & Rheumatology, August 2016, Wiley

    Dr. Jasvinder A. Singh

  172. How often is the office visit needed? Predicting total knee arthroplasty revision risk using pain/function scores

    Article • BMC Health Services Research, August 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  173. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015

    Article • The Lancet HIV, August 2016, Elsevier

    Dr Zahid A Butt, Dr marek majdan, Dr Amador Goodridge, Dr Arindam Basu, Dr Francis A Mhimbira, Kathryn H. Jacobsen, Dr Samer Hamidi, Professor David M. Pereira, Maysaa El Sayed Zaki, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, PhD. Carla Sofia FARINHA, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Dr. Bolajoko O. Olusanya, Rajaa Al-Raddadi

  174. Emergency Department and Inpatient Healthcare utilization due to Hypertension

    Article • BMC Health Services Research, July 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  175. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels

    Article • International Journal of Pharmaceutics, July 2016, Elsevier

    Dr. Jasvinder A. Singh

  176. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

    Article • BMJ, June 2016, BMJ

    Dr. Jasvinder A. Singh

  177. Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure

    Article • Annals of the Rheumatic Diseases, June 2016, BMJ

    Dr. Jasvinder A. Singh

  178. Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty

    Article • BMC Musculoskeletal Disorders, June 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  179. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Article • Cochrane Database of Systematic Reviews, May 2016, Wiley

    Dr. Jasvinder A. Singh

  180. Allopurinol treatment of gout and the risk of heart rhythm problem in elderly

    Article • Annals of the Rheumatic Diseases, May 2016, BMJ

    Dr. Jasvinder A. Singh

  181. Do pessimists report worse outcomes after total hip arthroplasty?

    Article • BMC Musculoskeletal Disorders, May 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  182. Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study

    Article • The Journal of Rheumatology, May 2016, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  183. Reply

    Article • Arthritis Care & Research, April 2016, Wiley

    Dr. Jasvinder A. Singh

  184. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

    Article • Arthritis Care & Research, April 2016, Wiley

    Dr Douglas White, Dr. Jasvinder A. Singh

  185. Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adults

    Article • Cochrane Database of Systematic Reviews, April 2016, Wiley

    Dr. Jasvinder A. Singh

  186. The Global Burden of Anemia

    Article • Hematology/Oncology Clinics of North America, April 2016, Elsevier

    Maysaa El Sayed Zaki, Professor Amanda G Thrift, Professor Yousef Khader, Dr. Jasvinder A. Singh

  187. Ms. A.M. Taylor, et al reply

    Article • The Journal of Rheumatology, April 2016, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  188. Racial/Ethnic Disparity in Rates and Outcomes of Total Joint Arthroplasty

    Article • Current Rheumatology Reports, March 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  189. Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis: to worry or not to worry?

    Article • Annals of the Rheumatic Diseases, March 2016, BMJ

    Dr. Jasvinder A. Singh

  190. Gout-related inpatient utilization: a study of predictors of outcomes and time trends

    Article • March 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  191. A cross-sectional internet-based patient survey of the management strategies for gout

    Article • BMC Complementary and Alternative Medicine, March 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  192. Performance of Gout Impact Scale in a longitudinal observational study of patients with gout

    Article • Rheumatology, February 2016, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  193. Reply

    Article • Arthritis & Rheumatology, February 2016, Wiley

    Dr. Jasvinder A. Singh

  194. Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health

    Article • Journal of Clinical Epidemiology, February 2016, Elsevier

    Dr. Jasvinder A. Singh

  195. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, January 2016, BMJ

    Dr. Jasvinder A. Singh

  196. Validation of the Mayo Hip Score: construct validity, reliability and responsiveness to change

    Article • BMC Musculoskeletal Disorders, January 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  197. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS)

    Article • January 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  198. PROMs for Gouty Arthritis

    Article • January 2016, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  199. Depression and Anxiety following Coronary Artery Bypass Graft: Current Indian Scenario

    Article • Cardiology Research and Practice, January 2016, Hindawi Publishing Corporation

    Dr Suprakash Chaudhury, Dr. Jasvinder A. Singh

  200. 10.1016/S0140-6736(15)60692-4

    Article • The Lancet, December 2015, Elsevier

    Dr Lorenzo Monasta, Professor David M. Pereira, Dr Francis A Mhimbira, Nadine Steckling, Dr marek majdan, Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Dr Azmeraw Amare, Ione Schneider, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez, Dr. Bolajoko O. Olusanya

  201. A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database

    Article • JCR Journal of Clinical Rheumatology, December 2015, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  202. Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making

    Article • Arthritis Research & Therapy, December 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  203. Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: a prospective cohort study

    Article • BMC Medicine, November 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  204. When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis

    Article • Arthritis Care & Research, November 2015, Wiley

    Dr. Jasvinder A. Singh

  205. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Article • Arthritis & Rheumatology, November 2015, Wiley

    Dr. Jasvinder A. Singh

  206. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Article • Arthritis Care & Research, November 2015, Wiley

    Dr. Jasvinder A. Singh

  207. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition

    Article • The Lancet, November 2015, Elsevier

    Professor David M. Pereira, Dr Lorenzo Monasta, Dr Francis A Mhimbira, Dr marek majdan, prof alberto ortiz , Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Dr Azmeraw Amare, Ione Schneider, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya

  208. Age-related differences in the use of total shoulder arthroplasty over time: use and outcomes

    Article • The Bone & Joint Journal, October 2015, Bone & Joint

    Dr. Jasvinder A. Singh

  209. Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index

    Article • Rheumatology International, October 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  210. Do “Evidence-Based Recommendations” Need to Reveal the Evidence? Minimal Criteria Supporting an “Evidence Claim”

    Article • The Journal of Rheumatology, October 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  211. A Call for Evidence-based Decision Making When Selecting Outcome Measurement Instruments for Summary of Findings Tables in Systematic Reviews: Results from an OMERACT Working Group

    Article • The Journal of Rheumatology, September 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  212. Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda

    Article • The Journal of Rheumatology, September 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  213. 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Article • Arthritis & Rheumatology, September 2015, Wiley

    Dr. Jasvinder A. Singh

  214. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

    Article • Annals of the Rheumatic Diseases, September 2015, BMJ

    Dr. Jasvinder A. Singh

  215. Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort

    Article • Arthritis Research & Therapy, September 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  216. Validity and sensitivity to change of three scales for the radiographic assessment of knee osteoarthritis using images from the Multicenter Osteoarthritis Study (MOST)

    Article • Osteoarthritis and Cartilage, September 2015, Elsevier

    Dr. Jasvinder A. Singh

  217. Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes

    Article • Journal of Racial and Ethnic Health Disparities, August 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  218. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists

    Article • PLoS ONE, August 2015, PLOS

    Dr. Jasvinder A. Singh

  219. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, August 2015, Elsevier

    Professor David M. Pereira, Dr Farshad Pourmalek, Dr Francis A Mhimbira, Dr marek majdan, Nadine Steckling, prof alberto ortiz , Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez

  220. Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT

    Article • The Journal of Rheumatology, August 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  221. Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique

    Article • The Journal of Rheumatology, July 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  222. The Global Burden of Cancer 2013

    Article • JAMA Oncology, July 2015, American Medical Association (AMA)

    Dr Robert Dellavalle, Dr Lorenzo Monasta, Professor David M. Pereira, Kathryn H. Jacobsen, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Dr Mark A Green, Dr. Jasvinder A. Singh, Tommi Vasankari

  223. Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic Pain

    Article • The Journal of Rheumatology, July 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  224. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

    Article • The Lancet, July 2015, Elsevier

    Dr. Jasvinder A. Singh

  225. Total joint replacement surgery for knee osteoarthritis and other non-traumatic diseases: a network meta-analysis

    Article • Cochrane Database of Systematic Reviews, June 2015, Wiley

    Dr. Jasvinder A. Singh

  226. Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures

    Article • The Journal of Rheumatology, June 2015, The Journal of Rheumatology

    Dr. Vivian Andrea Welch, Dr. Jasvinder A. Singh, Prof Tuncay Duruöz

  227. Investigational drugs for hyperuricemia

    Article • Expert Opinion on Investigational Drugs, June 2015, Informa Healthcare

    Dr. Jasvinder A. Singh

  228. Subcutaneous or intramuscular methotrexate for rheumatoid arthritis

    Article • Cochrane Database of Systematic Reviews, June 2015, Wiley

    Dr. Jasvinder A. Singh

  229. Validation of Administrative Codes for Calcium Pyrophosphate Deposition

    Article • JCR Journal of Clinical Rheumatology, June 2015, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  230. An Internet Survey of Common Treatments Used by Patients With Gout Including Cherry Extract and Juice and Other Dietary Supplements

    Article • JCR Journal of Clinical Rheumatology, June 2015, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  231. The OMERACT First-time Participant (“Newbie”) Program: Initial Assessment and Lessons Learned

    Article • The Journal of Rheumatology, June 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  232. Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study

    Article • Arthritis Research & Therapy, May 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  233. Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop

    Article • The Journal of Rheumatology, May 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  234. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort

    Article • Arthritis Research & Therapy, May 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  235. Does Hospital Volume Predict Outcomes and Complications After Total Shoulder Arthroplasty in the US?

    Article • Arthritis Care & Research, May 2015, Wiley

    Dr. Jasvinder A. Singh

  236. Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT Objective

    Article • The Journal of Rheumatology, May 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  237. Rheumatoid Arthritis is Associated With Higher Ninety-Day Hospital Readmission Rates Compared to Osteoarthritis After Hip or Knee Arthroplasty: A Cohort Study

    Article • Arthritis Care & Research, April 2015, Wiley

    Dr. Jasvinder A. Singh

  238. TNF-alpha inhibitors for ankylosing spondylitis

    Article • Cochrane Database of Systematic Reviews, April 2015, Wiley

    Dr. Jasvinder A. Singh

  239. Muscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty?

    Article • AJP Endocrinology and Metabolism, April 2015, American Physiological Society

    Dr. Jasvinder A. Singh

  240. Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

    Article • Clinical Orthopaedics and Related Research, April 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  241. Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative

    Article • The Journal of Rheumatology, April 2015, The Journal of Rheumatology

    Mr Peter DH Wall, Dr. Jasvinder A. Singh

  242. Are there racial disparities in utilization and outcomes after total elbow arthroplasty?

    Article • Rheumatology International, March 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  243. Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults

    Article • March 2015, Wiley

    Dr. Jasvinder A. Singh

  244. Racial disparities in total ankle arthroplasty utilization and outcomes

    Article • Arthritis Research & Therapy, March 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  245. Regional analgesia versus no regional analgesia for ambulatory hip arthroscopy in adults

    Article • March 2015, Wiley

    Dr. Jasvinder A. Singh

  246. Does rural residence impact total ankle arthroplasty utilization and outcomes?

    Article • Clinical Rheumatology, March 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  247. Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

    Article • Osteoporosis International, March 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  248. Is the Double Contour Sign Specific for Gout? Or Only for Crystal Arthritis?

    Article • The Journal of Rheumatology, March 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  249. Exercise therapy following surgical rotator cuff repair

    Article • Cochrane Database of Systematic Reviews, February 2015, Wiley

    Dr. Jasvinder A. Singh

  250. Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group

    Article • The Journal of Rheumatology, February 2015, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  251. Chondroitin for osteoarthritis

    Article • January 2015, Wiley

    Dr. Jasvinder A. Singh

  252. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration

    Article • Annals of the Rheumatic Diseases, January 2015, BMJ

    Dr. Jasvinder A. Singh

  253. When gout goes to the heart: does gout equal a cardiovascular disease risk factor?

    Article • Annals of the Rheumatic Diseases, January 2015, BMJ

    Dr. Jasvinder A. Singh

  254. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, January 2015, Elsevier

    Mr Heresh Amini, Professor David M. Pereira, Dr Francis A Mhimbira, Dr Farshad Pourmalek, Dr marek majdan, prof alberto ortiz , Dr Arindam Basu, Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Professor Amanda G Thrift, Hiroshi Yatsuya, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Professor Alina Rodriguez, Dr. Bolajoko O. Olusanya, Professor ORISH EBERE ORSAKWE

  255. Dependence on Walking Aids and Patient-Reported Outcomes after Total Knee Arthroplasty

    Article • Journal of Arthritis, January 2015, OMICS Publishing Group

    Dr. Jasvinder A. Singh

  256. Consensus on the need for a hierarchical list of patient-reported pain outcomes for meta-analyses of knee osteoarthritis trials

    Article • Current Controlled Trials in Cardiovascular Medicine, January 2015, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  257. Patient-centered priorities for improving medication management and adherence

    Article • Patient Education and Counseling, January 2015, Elsevier

    Dr. Jasvinder A. Singh

  258. Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

    Article • Health and Quality of Life Outcomes, December 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  259. Patient-centered interventions to improve medication management and adherence: A qualitative review of research findings

    Article • Patient Education and Counseling, December 2014, Elsevier

    Dr. Jasvinder A. Singh

  260. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)

    Article • British Journal of Dermatology, November 2014, Wiley

    Dr. Jasvinder A. Singh, Phyllis Spuls

  261. Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010

    Article • BMC Medicine, October 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  262. Remembering the forgotten non-communicable diseases

    Article • BMC Medicine, October 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  263. Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample

    Article • Clinical Rheumatology, October 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  264. Impaired response or insufficient dosage?—Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout

    Article • Seminars in Arthritis and Rheumatism, October 2014, Elsevier

    Dr. Jasvinder A. Singh

  265. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials

    Article • Journal of Allergy and Clinical Immunology, October 2014, Elsevier

    Dr. Jasvinder A. Singh, Phyllis Spuls

  266. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

    Article • BMJ, September 2014, BMJ

    Dr Romina Brignardello-Petersen, Dr. Jasvinder A. Singh

  267. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, September 2014, Elsevier

    Dr Zacharie Tsala Dimbuene, Dr Abdullah Sulieman Terkawi, Dr Lorenzo Monasta, Dr Farshad Pourmalek, Maysaa El Sayed Zaki, Dr Azmeraw Amare, Mr Raimundas Lunevicius, Dr Mark A Green, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari

  268. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, September 2014, Elsevier

    Dr Zacharie Tsala Dimbuene, Dr Abdullah Sulieman Terkawi, Mr Heresh Amini, Professor David M. Pereira, Dr Lorenzo Monasta, Dr Farshad Pourmalek, Dr marek majdan, Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Dr Azmeraw Amare, Ione Schneider, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya, Professor ORISH EBERE ORSAKWE

  269. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, September 2014, Elsevier

    Dr Abdullah Sulieman Terkawi, Mr Heresh Amini, Professor David M. Pereira, Dr Lorenzo Monasta, Dr Farshad Pourmalek, Dr marek majdan, Kathryn H. Jacobsen, Maysaa El Sayed Zaki, Dr Azmeraw Amare, Professor Yousef Khader, Dr. Jasvinder A. Singh, Tommi Vasankari, Dr. Bolajoko O. Olusanya, Professor ORISH EBERE ORSAKWE

  270. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013

    Article • The Lancet, August 2014, Elsevier

    Dr Ruth W Kimokoti, Hiroshi Yatsuya, Tommi Vasankari, Dr Mark A Green, Professor Yousef Khader, Dr. Jasvinder A. Singh

  271. Bariatric Surgery Prior to Total Joint Arthroplasty May Not Provide Dramatic Improvements in Post-Arthroplasty Surgical Outcomes

    Article • The Journal of Arthroplasty, July 2014, Elsevier

    Dr. Jasvinder A. Singh

  272. Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Article • Journal of Clinical Epidemiology, July 2014, Elsevier

    Dr. Jasvinder A. Singh

  273. Methotrexate use and liver disease - a causal relationship?

    Article • British Journal of Dermatology, July 2014, Wiley

    Dr. Jasvinder A. Singh

  274. Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis

    Article • Arthritis Care & Research, June 2014, Wiley

    Dr. Jasvinder A. Singh

  275. Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample

    Article • Clinical Rheumatology, June 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  276. Time Trends in the Characteristics of Patients Undergoing Primary Total Knee Arthroplasty

    Article • Arthritis Care & Research, May 2014, Wiley

    Dr. Jasvinder A. Singh

  277. Comorbidities in Patients with Crystal Diseases and Hyperuricemia

    Article • Rheumatic Disease Clinics of North America, May 2014, Elsevier

    Dr. Jasvinder A. Singh

  278. Faculty of 1000 evaluation for Surgery versus physical therapy for a meniscal tear and osteoarthritis.

    Article • April 2014, Faculty of 1000, Ltd.

    Dr. Jasvinder A. Singh

  279. Challenges Faced by Patients in Gout Treatment

    Article • JCR Journal of Clinical Rheumatology, April 2014, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  280. Updating the OMERACT Filter: Discrimination and Feasibility

    Article • The Journal of Rheumatology, April 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  281. Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity

    Article • The Journal of Rheumatology, April 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  282. Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets

    Article • The Journal of Rheumatology, March 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  283. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update

    Article • Quality of Life Research, March 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  284. How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0

    Article • The Journal of Rheumatology, March 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  285. Research Priorities in Gout: The Patient Perspective

    Article • The Journal of Rheumatology, March 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  286. Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers

    Article • The Journal of Rheumatology, March 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  287. Editorial: Arthroplasty Outcomes Are Improving, but Why Isn't My Patient With Rheumatoid Arthritis Doing as Well?

    Article • Arthritis & Rheumatology, January 2014, Wiley

    Dr. Jasvinder A. Singh

  288. Predictors of pain medication use for arthroplasty pain after revision total knee arthroplasty

    Article • Rheumatology, January 2014, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  289. Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout

    Article • The Journal of Rheumatology, January 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  290. Reliability and Clinically Important Improvement Thresholds for Osteoarthritis Pain and Function Scales: A Multicenter Study

    Article • The Journal of Rheumatology, January 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  291. Cerebrovascular Disease Is Associated with Outcomes After Total Knee Arthroplasty: A US Total Joint Registry Study

    Article • The Journal of Arthroplasty, January 2014, Elsevier

    Dr. Jasvinder A. Singh

  292. The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  293. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  294. Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010

    Article • BMC Medicine, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  295. Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function

    Article • BMC Musculoskeletal Disorders, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  296. Are outcomes after total knee arthroplasty worsening over time? A time-trends study of activity limitation and pain outcomes

    Article • BMC Musculoskeletal Disorders, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  297. Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: A 13-year study of time trends

    Article • BMC Musculoskeletal Disorders, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  298. Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  299. OMERACT 11: International Consensus Conference on Outcome Measures in Rheumatology

    Article • The Journal of Rheumatology, January 2014, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  300. OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout

    Article • The Journal of Rheumatology, December 2013, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  301. Outcome Measures in Acute Gout: A Systematic Literature Review

    Article • The Journal of Rheumatology, December 2013, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  302. Update of Strategies to Translate Evidence from Cochrane Musculoskeletal Group Systematic Reviews for Use by Various Audiences

    Article • The Journal of Rheumatology, December 2013, The Journal of Rheumatology

    Dr. Vivian Andrea Welch, Dr. Jasvinder A. Singh

  303. Does Clinically Important Change in Function After Knee Replacement Guarantee Good Absolute Function? The Multicenter Osteoarthritis Study

    Article • The Journal of Rheumatology, December 2013, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  304. Updated Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews and Metaanalyses

    Article • The Journal of Rheumatology, December 2013, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  305. Better Functional and Similar Pain Outcomes in Osteoarthritis Compared to Rheumatoid Arthritis After Primary Total Knee Arthroplasty: A Cohort Study

    Article • Arthritis Care & Research, November 2013, Wiley

    Dr. Jasvinder A. Singh

  306. Ofatumumab for rheumatoid arthritis

    Article • Cochrane Database of Systematic Reviews, November 2013, Wiley

    Sushil Kumar Garg, Dr. Jasvinder A. Singh

  307. Diabetes: A Risk Factor for Poor Functional Outcome after Total Knee Arthroplasty

    Article • PLoS ONE, November 2013, PLOS

    Dr. Jasvinder A. Singh

  308. Underlying diagnosis predicts patient-reported outcomes after revision total knee arthroplasty

    Article • Rheumatology, November 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  309. Patient-level improvements in pain and activities of daily living after total knee arthroplasty

    Article • Rheumatology, October 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  310. Including Health Equity Considerations in Development of Instruments for Rheumatology Research: An Introduction to a Novel OMERACT Paradigm

    Article • The Journal of Rheumatology, October 2013, The Journal of Rheumatology

    Dr. Vivian Andrea Welch, Dr. Jasvinder A. Singh

  311. Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national medicare data

    Article • Annals of the Rheumatic Diseases, September 2013, BMJ

    Dr. Jasvinder A. Singh

  312. Total joint replacement surgery versus conservative care for knee osteoarthritis and other non-traumatic diseases

    Article • Cochrane Database of Systematic Reviews, September 2013, Wiley

    Dr. Jasvinder A. Singh

  313. Total hip replacement surgery versus conservative care for hip osteoarthritis and other non-traumatic diseases

    Article • Cochrane Database of Systematic Reviews, September 2013, Wiley

    Dr. Jasvinder A. Singh

  314. The State of US Health, 1990-2010

    Article • JAMA, August 2013, American Medical Association (AMA)

    Kathryn H. Jacobsen, Dr. Jasvinder A. Singh

  315. Medical Comorbidity is Associated with Persistent Index Hip Pain after Total Hip Arthroplasty

    Article • Pain Medicine, August 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  316. Perioperative interventions for smoking cessation in hip and knee arthroplasty for osteoarthritis and other non-traumatic diseases

    Article • Cochrane Database of Systematic Reviews, July 2013, Wiley

    Dr. Jasvinder A. Singh

  317. Belimumab for systemic lupus erythematosus

    Article • Cochrane Database of Systematic Reviews, July 2013, Wiley

    Dr. Jasvinder A. Singh

  318. Use of botulinum toxin in musculoskeletal pain

    Article • F1000Research, July 2013, Faculty of 1000, Ltd.

    Dr. Jasvinder A. Singh

  319. Folic Acid Supplementation for Rheumatoid Arthritis Patients on Methotrexate: The Good Gets Better

    Article • July 2013, Wiley

    Dr. Jasvinder A. Singh

  320. Acquired supravalvular pulmonary stenosis due to extrinsic compression by a mediastinal dermoid cyst

    Article • European Journal of Cardio-Thoracic Surgery, July 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  321. Sex and Surgical Outcomes and Mortality After Primary Total Knee Arthroplasty: A Risk‐Adjusted Analysis

    Article • Arthritis Care & Research, July 2013, Wiley

    Dr. Jasvinder A. Singh

  322. Participation Following Knee Replacement: The MOST Cohort Study

    Article • Physical Therapy, June 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  323. Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: feasibility, satisfaction, and sample size

    Article • Patient Preference and Adherence, June 2013, Taylor & Francis

    Dr. Jasvinder A. Singh

  324. The Influence of the Contralateral Knee Prior to Knee Arthroplasty on Post-Arthroplasty Function

    Article • Journal of Bone and Joint Surgery, June 2013, The Journal of Bone and Joint Surgery, Inc.

    Dr. Jasvinder A. Singh

  325. Reply

    Article • Arthritis Care & Research, April 2013, Wiley

    Dr. Jasvinder A. Singh

  326. Clinically Important Body Weight Gain Following Knee Arthroplasty: A Five-Year Comparative Cohort Study

    Article • Arthritis Care & Research, April 2013, Wiley

    Dr. Jasvinder A. Singh

  327. The relation between cancer patient treatment decision-making roles and quality of life

    Article • Cancer, April 2013, Wiley

    Dr. Jasvinder A. Singh

  328. Gout-Related Health Care Utilization in US Emergency Departments, 2006 Through 2008

    Article • Arthritis Care & Research, March 2013, Wiley

    Dr. Jasvinder A. Singh

  329. Income and patient-reported outcomes (PROs) after primary total knee arthroplasty

    Article • BMC Medicine, March 2013, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  330. Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate

    Article • Canadian Medical Association Journal, March 2013, Canadian Medical Association (CMA)

    Dr. Jasvinder A. Singh

  331. Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature

    Article • Immunotherapy, March 2013, Future Medicine

    Dr. Jasvinder A. Singh

  332. Use of botulinum toxin in musculoskeletal pain

    Article • F1000Research, February 2013, Faculty of 1000, Ltd.

    Dr. Jasvinder A. Singh

  333. Botox for Joints

    Article • F1000Research, February 2013, F1000Research

    Dr. Jasvinder A. Singh

  334. Crystal arthritis: Is HLAB genotyping the future of gout pharmacogenomics?

    Article • Nature Reviews Rheumatology, February 2013, Nature

    Dr. Jasvinder A. Singh

  335. Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry

    Article • Rheumatology, February 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  336. Faculty of 1000 evaluation for Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.

    Article • January 2013, Faculty of 1000, Ltd.

    Dr. Jasvinder A. Singh

  337. Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty

    Article • Rheumatology, January 2013, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  338. Predictors of periprosthetic fracture after total knee replacement

    Article • Acta Orthopaedica, January 2013, Taylor & Francis

    Dr. Jasvinder A. Singh

  339. Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty

    Article • BMC Medicine, January 2013, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  340. Veterans Affairs databases are accurate for gout-related health care utilization: a validation study

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  341. Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs)

    Article • BMC Musculoskeletal Disorders, January 2013, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  342. Are Gender, Comorbidity, and Obesity Risk Factors for Postoperative Periprosthetic Fractures After Primary Total Hip Arthroplasty?

    Article • The Journal of Arthroplasty, January 2013, Elsevier

    Dr. Jasvinder A. Singh

  343. Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study

    Article • BMC Medicine, January 2013, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  344. Clinically important body weight gain following total hip arthroplasty: a cohort study with 5-year follow-up

    Article • Osteoarthritis and Cartilage, January 2013, Elsevier

    Dr. Jasvinder A. Singh

  345. Mediation of smoking-associated postoperative mortality by perioperative complications in veterans undergoing elective surgery: data from Veterans Affairs Surgical Quality Improvement Program (VASQIP)—a cohort study

    Article • BMJ Open, January 2013, BMJ

    Dr. Jasvinder A. Singh

  346. Racial and Gender Disparities Among Patients with Gout

    Article • Current Rheumatology Reports, December 2012, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  347. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    Article • The Lancet, December 2012, Elsevier

    Dr Robert Dellavalle, Dr Lorenzo Monasta, Dr Farshad Pourmalek, Kathryn H. Jacobsen, Dr. Jasvinder A. Singh, Dr Timothy J H Lathlean

  348. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    Article • The Lancet, December 2012, Elsevier

    Dr Robert Dellavalle, Dr Lorenzo Monasta, Dr Farshad Pourmalek, Kathryn H. Jacobsen, Dr. Jasvinder A. Singh, Dr Timothy J H Lathlean

  349. Emerging therapies for gout

    Article • Expert Opinion on Emerging Drugs, November 2012, Informa Healthcare

    Dr. Jasvinder A. Singh

  350. Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective

    Article • Journal of Shoulder and Elbow Surgery, November 2012, Elsevier

    Dr. Jasvinder A. Singh

  351. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

    Article • Contemporary Clinical Trials, November 2012, Elsevier

    Dr. Jasvinder A. Singh

  352. Periprosthetic Fractures Associated with Primary Total Shoulder Arthroplasty and Primary Humeral Head Replacement

    Article • Journal of Bone and Joint Surgery, October 2012, The Journal of Bone and Joint Surgery, Inc.

    Dr. Jasvinder A. Singh

  353. Total Knee Arthroplasty in Morbidly Obese Patients Treated With Bariatric Surgery

    Article • The Journal of Arthroplasty, October 2012, Elsevier

    Dr. Jasvinder A. Singh

  354. Periprosthetic infections after shoulder hemiarthroplasty

    Article • Journal of Shoulder and Elbow Surgery, October 2012, Elsevier

    Dr. Jasvinder A. Singh

  355. Reply

    Article • Arthritis Care & Research, September 2012, Wiley

    Dr. Jasvinder A. Singh

  356. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Article • Arthritis Care & Research, September 2012, Wiley

    Dr. Jasvinder A. Singh

  357. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

    Article • Arthritis Care & Research, September 2012, Wiley

    Dr. Jasvinder A. Singh

  358. Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010

    Article • JAMA, September 2012, American Medical Association (AMA)

    Dr. Jasvinder A. Singh

  359. Patient Factors Predict Periprosthetic Fractures After Revision Total Hip Arthroplasty

    Article • The Journal of Arthroplasty, September 2012, Elsevier

    Dr. Jasvinder A. Singh

  360. Ninety-day Mortality in Patients Undergoing Elective Total Hip or Total Knee Arthroplasty

    Article • The Journal of Arthroplasty, September 2012, Elsevier

    Dr. Jasvinder A. Singh

  361. Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement

    Article • Acta Orthopaedica, August 2012, Taylor & Francis

    Dr. Jasvinder A. Singh

  362. Risk factors for revision surgery after humeral head replacement: 1,431 shoulders over 3 decades

    Article • Journal of Shoulder and Elbow Surgery, August 2012, Elsevier

    Dr. Jasvinder A. Singh

  363. Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials

    Article • The Journal of Rheumatology, June 2012, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  364. Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold?

    Article • BMC Medicine, May 2012, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  365. Summary of AHRQ’s Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis (RA) in Adults – An Update

    Article • Journal of Managed Care Pharmacy, May 2012, Academy of Managed Care Pharmacy

    Dr. Jasvinder A. Singh

  366. Developing a provisional definition of flare in patients with established gout

    Article • Arthritis & Rheumatism, April 2012, Wiley

    Dr. Jasvinder A. Singh

  367. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Article • Arthritis Care & Research, April 2012, Wiley

    Dr. Jasvinder A. Singh

  368. Cardiopulmonary Complications After Primary Shoulder Arthroplasty: A Cohort Study

    Article • Seminars in Arthritis and Rheumatism, April 2012, Elsevier

    Dr. Jasvinder A. Singh

  369. Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor

    Article • Clinical Therapeutics, April 2012, Elsevier

    Dr. Jasvinder A. Singh

  370. Can racial disparities in optimal gout treatment be reduced? evidence from a randomized trial

    Article • BMC Medicine, February 2012, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  371. A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data

    Article • Pharmacoepidemiology and Drug Safety, January 2012, Wiley

    Dr. Jasvinder A. Singh

  372. Quality of Care in Gout

    Article • January 2012, Elsevier

    Dr. Jasvinder A. Singh

  373. Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  374. The Attributable Risk of Smoking on Surgical Complications

    Article • Annals of Surgery, December 2011, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  375. Adverse Effects of Smoking on Postoperative Outcomes in Cancer Patients

    Article • Annals of Surgical Oncology, November 2011, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  376. Revision surgery following total shoulder arthroplasty: Analysis of 2588 shoulders over three decades (1976 to 2008)

    Article • The Bone & Joint Journal, November 2011, Bone & Joint

    Dr. Jasvinder A. Singh

  377. Gouty Arthritis

    Article • October 2011, Wiley

    Dr. Jasvinder A. Singh

  378. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty

    Article • Annals of the Rheumatic Diseases, October 2011, BMJ

    Dr. Jasvinder A. Singh

  379. Comparison of Patient-Reported and Clinician-Assessed Outcomes Following Total Knee Arthroplasty

    Article • Journal of Bone and Joint Surgery, October 2011, The Journal of Bone and Joint Surgery, Inc.

    Dr. Jasvinder A. Singh

  380. Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty

    Article • Arthritis Care & Research, September 2011, Wiley

    Dr. Jasvinder A. Singh

  381. Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans

    Article • Arthritis Care & Research, September 2011, Wiley

    Dr. Jasvinder A. Singh

  382. Hospital volume and surgical outcomes after elective hip/knee arthroplasty: A risk-adjusted analysis of a large regional database

    Article • Arthritis & Rheumatism, August 2011, Wiley

    Dr. Jasvinder A. Singh

  383. Developing a Construct to Evaluate Flares in Rheumatoid Arthritis: A Conceptual Report of the OMERACT RA Flare Definition Working Group: Table 1.

    Article • The Journal of Rheumatology, August 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  384. OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group

    Article • The Journal of Rheumatology, August 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  385. OMERACT 10 Patient Perspective Virtual Campus: Valuing Health; Measuring Outcomes in Rheumatoid Arthritis Fatigue, RA Sleep, Arthroplasty, and Systemic Sclerosis; and Clinical Significance of Changes in Health

    Article • The Journal of Rheumatology, August 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  386. Biologicals for rheumatoid arthritis

    Article • BMJ, July 2011, BMJ

    Dr. Jasvinder A. Singh

  387. Bringing It All Together: A Novel Approach to the Development of Response Criteria for Chronic Gout Clinical Trials

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  388. Early Postoperative Mortality Following Joint Arthroplasty: A Systematic Review

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  389. Intraarticular Botulinum Toxin A for Refractory Painful Total Knee Arthroplasty: A Randomized Controlled Trial

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  390. Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  391. Serum Urate in Chronic Gout — Will It Be the First Validated Soluble Biomarker in Rheumatology?

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  392. Tophus Measurement as an Outcome Measure for Clinical Trials of Chronic Gout: Progress and Research Priorities

    Article • The Journal of Rheumatology, July 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  393. Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study

    Article • Arthritis Care & Research, June 2011, Wiley

    Dr. Jasvinder A. Singh

  394. Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care

    Article • Clinical Therapeutics, June 2011, Elsevier

    Dr. Jasvinder A. Singh

  395. Health Care Utilization in Patients with Gout

    Article • Seminars in Arthritis and Rheumatism, June 2011, Elsevier

    Dr. Jasvinder A. Singh

  396. Smoking and Outcomes After Knee and Hip Arthroplasty: A Systematic Review

    Article • The Journal of Rheumatology, June 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  397. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials

    Article • Annals of the Rheumatic Diseases, May 2011, BMJ

    Dr. Jasvinder A. Singh

  398. Responsiveness differences in outcome instruments after revision hip arthroplasty: What are the implications?

    Article • BMC Musculoskeletal Disorders, May 2011, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  399. Higher Body Mass Index Is Not Associated With Worse Pain Outcomes After Primary or Revision Total Knee Arthroplasty

    Article • The Journal of Arthroplasty, April 2011, Elsevier

    Dr. Jasvinder A. Singh

  400. Editorial - Current Concepts in Arthroplasty§

    Article • The Open Orthopaedics Journal, March 2011, Bentham Science Publishers

    Dr. Jasvinder A. Singh

  401. Epidemiology of Knee and Hip Arthroplasty: A Systematic Review§

    Article • The Open Orthopaedics Journal, March 2011, Bentham Science Publishers

    Dr. Jasvinder A. Singh

  402. Diagnosis and Management of Infected Total Knee Arthroplasty§

    Article • The Open Orthopaedics Journal, March 2011, Bentham Science Publishers

    Dr. Jasvinder A. Singh

  403. Biomarkers in Arthroplasty: A Systematic Review

    Article • The Open Orthopaedics Journal, March 2011, Bentham Science Publishers

    Dr. Jasvinder A. Singh

  404. Minimally important differences of the gout impact scale in a randomized controlled trial

    Article • Rheumatology, March 2011, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  405. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Article • Cochrane Database of Systematic Reviews, February 2011, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh, ScD MSc LUCIANE CRUZ LOPES

  406. Risk factors for gout and prevention: a systematic review of the literature

    Article • Current Opinion in Rheumatology, February 2011, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  407. Botulinum Toxin for Shoulder Pain: A Cochrane Systematic Review

    Article • The Journal of Rheumatology, February 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  408. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement

    Article • Osteoarthritis and Cartilage, February 2011, Elsevier

    Dr. Jasvinder A. Singh

  409. Surgery for Shoulder Osteoarthritis: A Cochrane Systematic Review

    Article • The Journal of Rheumatology, January 2011, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  410. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2011, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  411. Ninety day mortality and its predictors after primary shoulder arthroplasty: an analysis of 4,019 patients from 1976-2008

    Article • BMC Musculoskeletal Disorders, January 2011, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  412. Predictors of Activity Limitation and Dependence on Walking Aids After Primary Total Hip Arthroplasty

    Article • Journal of the American Geriatrics Society, December 2010, Wiley

    Dr. Jasvinder A. Singh

  413. Accuracy of VA databases for diagnoses of knee replacement and hip replacement

    Article • Osteoarthritis and Cartilage, December 2010, Elsevier

    Dr. Jasvinder A. Singh

  414. Extramediastinal thymolipomas—challenges in diagnosis and dilemmas in approaches: a review

    Article • Indian Journal of Thoracic and Cardiovascular Surgery, October 2010, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  415. Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review

    Article • The Journal of Rheumatology, October 2010, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  416. Surgery for shoulder osteoarthritis

    Article • Cochrane Database of Systematic Reviews, October 2010, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh

  417. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Article • October 2010, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh

  418. Predictors of Moderate-Severe Functional Limitation 2 and 5 Years After Revision Total Knee Arthroplasty

    Article • The Journal of Arthroplasty, October 2010, Elsevier

    Dr. Jasvinder A. Singh

  419. A Population-Based Study of Trends in the Use of Total Hip and Total Knee Arthroplasty, 1969-2008

    Article • Mayo Clinic Proceedings, October 2010, Elsevier

    Dr. Jasvinder A. Singh

  420. Botulinum toxin for shoulder pain

    Article • Cochrane Database of Systematic Reviews, September 2010, Wiley

    Dr. Jasvinder A. Singh

  421. Gout in the Hmong in the United States

    Article • JCR Journal of Clinical Rheumatology, September 2010, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  422. Intraarticular Botulinum Toxin A for Refractory Painful Total Knee Arthroplasty: A Randomized Controlled Trial

    Article • The Journal of Rheumatology, September 2010, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  423. Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment

    Article • Journal of Evaluation in Clinical Practice, August 2010, Wiley

    Dr. Jasvinder A. Singh

  424. Tocilizumab for rheumatoid arthritis

    Article • July 2010, Wiley

    Dr. Jasvinder A. Singh

  425. Pessimistic explanatory style: A PSYCHOLOGICAL RISK FACTOR FOR POOR PAIN AND FUNCTIONAL OUTCOMES TWO YEARS AFTER KNEE REPLACEMENT

    Article • Journal of Bone and Joint Surgery - British Volume, May 2010, Bone & Joint

    Dr. Jasvinder A. Singh

  426. Golimumab for Rheumatoid Arthritis: A Systematic Review

    Article • The Journal of Rheumatology, May 2010, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  427. Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study

    Article • PM&R, April 2010, Elsevier

    Dr Andrea J Boon, Dr. Jasvinder A. Singh

  428. Predictors of moderate–severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years

    Article • Osteoarthritis and Cartilage, April 2010, Elsevier

    Dr. Jasvinder A. Singh

  429. Pegloticase for chronic gout

    Article • Cochrane Database of Systematic Reviews, March 2010, Wiley

    Dr. Jasvinder A. Singh

  430. A national survey of Veterans Affairs Rheumatologists for relevance of quality of care indicators for Gout management

    Article • Arthritis Care & Research, March 2010, Wiley

    Dr. Jasvinder A. Singh

  431. Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review

    Article • The Journal of Rheumatology, March 2010, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  432. Trial sample size, but not trial quality, is associated with positive study outcome

    Article • Journal of Clinical Epidemiology, February 2010, Elsevier

    Dr. Jasvinder A. Singh

  433. Challenges With Health-related Quality of Life Assessment in Arthroplasty Patients: Problems and Solutions

    Article • Journal of the American Academy of Orthopaedic Surgeons, February 2010, American Academy of Orthopaedic Surgeons

    Dr. Jasvinder A. Singh

  434. Golimumab for rheumatoid arthritis

    Article • Cochrane Database of Systematic Reviews, January 2010, Wiley

    Dr. Jasvinder A. Singh

  435. Tocilizumab for rheumatoid arthritis

    Article • January 2010, Wiley

    Dr. Jasvinder A. Singh

  436. Pegloticase for chronic gout

    Article • January 2010, Wiley

    Dr. Jasvinder A. Singh

  437. Botulinum toxin for shoulder pain

    Article • January 2010, Wiley

    Dr. Jasvinder A. Singh

  438. Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review

    Article • The Journal of Rheumatology, January 2010, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  439. Botulinum toxin therapy for osteoarticular pain: an evidence-based review

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2010, SAGE Publications

    Dr. Jasvinder A. Singh

  440. Newer Biological Agents in Rheumatoid Arthritis

    Article • Drugs, January 2010, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  441. Applying science in practice: the optimization of biological therapy in rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  442. Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years

    Article • BMC Musculoskeletal Disorders, January 2010, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  443. Advances in gout: some answers, more questions

    Article • Arthritis Research & Therapy, January 2010, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  444. Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases

    Article • Annals of the Rheumatic Diseases, November 2009, BMJ

    Dr. Jasvinder A. Singh

  445. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

    Article • Canadian Medical Association Journal, November 2009, Canadian Medical Association (CMA)

    Dr. Jasvinder A. Singh

  446. Assessment of the Methodologic Quality of Medical and Surgical Clinical Trials in Patients with Arthroplasty

    Article • The Journal of Rheumatology, November 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  447. Surgery for shoulder osteoarthritis

    Article • October 2009, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh

  448. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Article • October 2009, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh

  449. Abatacept for rheumatoid arthritis

    Article • Cochrane Database of Systematic Reviews, October 2009, Wiley

    Dr. Jasvinder A. Singh

  450. Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain

    Article • Toxicon, October 2009, Elsevier

    Dr. Jasvinder A. Singh

  451. Outcome Domains for Studies of Acute and Chronic Gout

    Article • The Journal of Rheumatology, October 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  452. Progress in Measurement Instruments for Acute and Chronic Gout Studies

    Article • The Journal of Rheumatology, October 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  453. Mobile and Fixed-Bearing (All-Polyethylene Tibial Component) Total Knee Arthroplasty Designs

    Article • Journal of Bone and Joint Surgery, September 2009, The Journal of Bone and Joint Surgery, Inc.

    Dr. Jasvinder A. Singh

  454. Variation in Outcome Measures in Hip and Knee Arthroplasty Clinical Trials: A Proposed Approach to Achieving Consensus

    Article • The Journal of Rheumatology, September 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  455. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty

    Article • Clinical Rheumatology, August 2009, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  456. Discordance Between Self-report of Physician Diagnosis and Administrative Database Diagnosis of Arthritis and Its Predictors

    Article • The Journal of Rheumatology, August 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  457. Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty

    Article • Clinical Rheumatology, June 2009, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  458. The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-Reported Quality-of-Life Outcomes

    Article • Twin Research and Human Genetics, June 2009, Cambridge University Press

    Professor Dorret I Boomsma, Dr. Jasvinder A. Singh

  459. Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty

    Article • Clinical Rheumatology, May 2009, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  460. Anakinra for Rheumatoid Arthritis: A Systematic Review

    Article • The Journal of Rheumatology, May 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  461. Effect of resistance exercise on bone mineral density in premenopausal women

    Article • Joint Bone Spine, May 2009, Elsevier

    Dr. Jasvinder A. Singh

  462. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial

    Article • Translational Research, May 2009, Elsevier

    Dr. Jasvinder A. Singh

  463. Effet des exercices de renforcement musculaire sur la densité minérale osseuse chez les femmes en période de préménopause

    Article • Revue du Rhumatisme, May 2009, Elsevier

    Dr. Jasvinder A. Singh

  464. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Article • April 2009, Wiley

    Professor Rachelle Buchbinder, Dr. Jasvinder A. Singh

  465. Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of Life

    Article • The Journal of Rheumatology, April 2009, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  466. Toward a valid definition of gout flare: Results of consensus exercises using delphi methodology and cognitive mapping

    Article • Arthritis & Rheumatism, April 2009, Wiley

    Dr. Jasvinder A. Singh

  467. Quality of life and quality of care for patients with gout

    Article • Current Rheumatology Reports, March 2009, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  468. Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases

    Article • Joint Bone Spine, March 2009, Elsevier

    Dr. Jasvinder A. Singh

  469. Utilisation de la toxine A botulique en intra-articulaire pour douleur résistante locales chez des polyarthrites rhumatoïdes traitées par biothérapies : deux observations

    Article • Revue du Rhumatisme, March 2009, Elsevier

    Dr. Jasvinder A. Singh

  470. Anakinra for rheumatoid arthritis

    Article • Cochrane Database of Systematic Reviews, January 2009, Wiley

    Dr. Jasvinder A. Singh

  471. Health-Related Quality of Life in Rheumatoid Arthritis

    Article • January 2009, Elsevier

    Dr. Jasvinder A. Singh

  472. Health Care Costs in Gout

    Article • JCR Journal of Clinical Rheumatology, January 2009, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  473. Repeat Injections of Intra-Articular Botulinum Toxin A for the Treatment of Chronic Arthritis Joint Pain

    Article • JCR Journal of Clinical Rheumatology, January 2009, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  474. Botulinum Toxin for Osteoarticular Pain

    Article • January 2009, Elsevier

    Dr. Jasvinder A. Singh

  475. Perceptions of disease and health-related quality of life among patients with gout

    Article • Rheumatology, December 2008, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  476. Can patients help with long-term total knee arthroplasty surveillance? Comparison of the American Knee Society Score self-report and surgeon assessment

    Article • Rheumatology, December 2008, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  477. Health care utilization in patients with spondyloarthropathies

    Article • Rheumatology, October 2008, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  478. Evaluation of an Instrument Assessing Influence of Gout on Health-Related Quality of Life

    Article • The Journal of Rheumatology, October 2008, The Journal of Rheumatology

    Dr. Jasvinder A. Singh

  479. Health-related quality of life in veterans with prevalent total knee arthroplasty and total hip arthroplasty

    Article • Rheumatology, October 2008, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  480. Chronic Constrictive Calcific Pericarditis

    Article • Asian Cardiovascular and Thoracic Annals, October 2008, SAGE Publications

    Dr. Jasvinder A. Singh

  481. Opportunities for improving medication use and monitoring in gout

    Article • Annals of the Rheumatic Diseases, August 2008, BMJ

    Dr. Jasvinder A. Singh

  482. The Impact of Gender, Age, and Preoperative Pain Severity on Pain After TKA

    Article • Clinical Orthopaedics and Related Research, August 2008, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  483. Abatacept for rheumatoid arthritis

    Article • July 2008, Wiley

    Dr. Jasvinder A. Singh

  484. Anakinra for rheumatoid arthritis

    Article • April 2008, Wiley

    Dr. Jasvinder A. Singh

  485. Surgical Management of Aortic Stenosis in a Child

    Article • Medical Journal Armed Forces India, April 2008, Elsevier

    Dr. Jasvinder A. Singh

  486. Age and Sex are Predictors of Moderate to Severe Pain Post Total Knee Arthroplasty

    Article • The Journal of Arthroplasty, February 2008, Elsevier

    Dr. Jasvinder A. Singh

  487. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout

    Article • Annals of the Rheumatic Diseases, January 2008, BMJ

    Dr. Jasvinder A. Singh

  488. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans

    Article • Annals of the Rheumatic Diseases, November 2007, BMJ

    Dr. Jasvinder A. Singh

  489. Assessment of outcome in clinical trials of gout a review of current measures

    Article • Rheumatology, August 2007, Oxford University Press (OUP)

    Dr. Jasvinder A. Singh

  490. The effects of intra-articular botulinum toxin on sacroiliac, cervical/lumbar facet and sterno-clavicular joint pain and C-2 root and lumbar disc pain: a case series of 11 patients

    Article • The Pain Clinic, August 2007, Taylor & Francis

    Dr. Jasvinder A. Singh

  491. Effect of Health-Related Quality of Life on Women and Men’s Veterans Affairs (VA) Health Care Utilization and Mortality

    Article • Journal of General Internal Medicine, July 2007, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  492. Contributions of OMERACT to rheumatic disease research

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Dr. Jasvinder A. Singh

  493. Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Dr. Jasvinder A. Singh

  494. Classification criteria in rheumatic diseases: A review of methodologic properties

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Dr. Jasvinder A. Singh

  495. Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Dr. Jasvinder A. Singh

  496. Quality of care for gout in the US needs improvement

    Article • Arthritis & Rheumatism, January 2007, Wiley

    Dr. Jasvinder A. Singh

  497. Spondyloarthropathy: An Independent Risk Factor for Kidney Stones

    Article • Journal of Endourology, August 2006, Mary Ann Liebert Inc

    Dr. Jasvinder A. Singh

  498. Antibiotics for reactive arthritis

    Article • Cochrane Database of Systematic Reviews, July 2006, Wiley

    Dr. Jasvinder A. Singh

  499. Development of classification and response criteria for rheumatic diseases

    Article • Arthritis & Rheumatism, June 2006, Wiley

    Dr. Jasvinder A. Singh

  500. Long term effects of intra-articular botulinum toxin a for refractory joint pain

    Article • Neurotoxicity Research, June 2006, Springer Science + Business Media

    Dr. Jasvinder A. Singh

  501. Chondroitin for osteoarthritis

    Article • January 2006, Wiley

    Dr. Jasvinder A. Singh

  502. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases

    Article • American Journal of Hematology, January 2006, Wiley

    Dr. Jasvinder A. Singh

  503. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study

    Article • Seminars in Arthritis and Rheumatism, April 2005, Elsevier

    Dr. Jasvinder A. Singh

  504. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report

    Article • Lupus, February 2005, SAGE Publications

    Dr. Jasvinder A. Singh

  505. Opioid use by patients in an orthopedics spine clinic

    Article • Arthritis & Rheumatism, January 2005, Wiley

    Dr. Jasvinder A. Singh

  506. Health-Related Quality of Life, Functional Impairment, and Healthcare Utilization by Veterans: Veterans' Quality of Life Study

    Article • Journal of the American Geriatrics Society, January 2005, Wiley

    Dr. Jasvinder A. Singh

  507. Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis

    Article • Arthritis & Rheumatism, December 2004, Wiley

    Dr. Jasvinder A. Singh

  508. Poster 7 intra-articular botulinum toxin type A for refractory joint pain. Maren L. Mahowald, MD (Minneapolis VA Med Ctr/Univ Minnesota, Minneapolis, MN); Jasvinder A. Singh, MD, MPH; Dennis D. Dykstra, MD, PhD, e-mail: mahow001@umn.edu

    Article • Archives of Physical Medicine and Rehabilitation, September 2004, Elsevier

    Dr. Jasvinder A. Singh

  509. Immunohistochemistry of normal human knee synovium: a quantitative study

    Article • Annals of the Rheumatic Diseases, July 2004, BMJ

    Dr. Jasvinder A. Singh

  510. Leflunomide use during the first 33 months after food and drug administration approval: Experience with a national cohort of 3,325 patients

    Article • Arthritis & Rheumatism, December 2003, Wiley

    Dr. Jasvinder A. Singh

  511. Talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals in sisters: A new syndrome?

    Article • American Journal of Medical Genetics, August 2003, Wiley

    Dr. Jasvinder A. Singh

  512. Ciprofloxacin-Related Acute Peripheral Neuropathy in a Patient With Lupus Nephritis

    Article • JCR Journal of Clinical Rheumatology, June 2002, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  513. Pulmonary Takayasu???s Arteritis Masquerading as Acute Pulmonary Embolism

    Article • JCR Journal of Clinical Rheumatology, December 2001, Wolters Kluwer Health

    Dr. Jasvinder A. Singh

  514. Synthesis of 2-Methylheptadecane and 14-Methylpentadecan-3-one

    Article • Collection of Czechoslovak Chemical Communications, January 1994, Institute of Organic Chemistry & Biochemistry

    Dr. Jasvinder A. Singh

  515. The use of botulinum neurotoxin in musculoskeletal pain and arthritis

    Article • Cambridge University Press

    Dr. Jasvinder A. Singh

  516. Gender and Arthroplasty Type Affect Prevalence of Moderate-Severe Pain Post Total Hip Arthroplasty

    Article • Springer Science + Business Media

    Dr. Jasvinder A. Singh